Steven A. Shallcross - 20 Jan 2023 Form 4 Insider Report for Theriva Biologics, Inc. (TOVX)

Signature
/s/ Steven A. Shallcross
Issuer symbol
TOVX
Transactions as of
20 Jan 2023
Net transactions value
+$18,705
Form type
4
Filing time
23 Jan 2023, 05:08:18 UTC
Previous filing
03 Jan 2023
Next filing
26 Jan 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOVX Common Stock Purchase $18,705 +25,000 +23% $0.7482 135,000 20 Jan 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.